This is a service of EIN News a digital news provider
Healthcare Industry Today
Sign up for a free trial
Register Now
Member center Log In
Anemia Drugs News is an EIN News Service for health professionals. Constantly updated news and information about health.
FORMATS: RSS | EMAIL

Latest Anemia Drugs News

Sort by: relevance (24 hours) relevance date
  • Amgen Stock Stable Despite Bad News Tied to Drug 8 Nov 2009 00:35 GMT
    ... Stock Stable Despite Bad News Tied to Drug BIOTECH: Aranesp generates poor test results and ... Oaks biotech giant, much like its predecessor anti-anemia drug Epogen. These days, Aranesp might be ... was approved for anemia related to cancer treatment, a market once dominated by Procrit. Amgen ...

  • FDA Approves Gloucester Pharmaceuticals' Istodax for Patients with Cutaneous T-cell Lymphoma 7 Nov 2009 00:53 GMT
    ... announced today that the U.S. Food and Drug Administration (FDA) approved (romidepsin) for the treatment of cutaneous T-cell lymphoma (CTCL) in patients ... and in Study 2 were nausea, fatigue, anemia, thrombocytopenia, ECG T-wave changes, neutropenia and lymphopenia. ...

  • FDA Approves Gloucester Pharmaceuticals' ISTODAX(R) For Patients With Cutaneous T-cell Lymphoma 7 Nov 2009 00:51 GMT
    ... announced today that the U.S. Food and Drug Administration (FDA) approved ISTODAX® (romidepsin) for the ... Administration (FDA) approved ISTODAX® (romidepsin) for the treatment of cutaneous T-cell (CTCL) in patients who ... cause thrombocytopenia, leukopenia (neutropenia and lymphopenia), and anemia; therefore, these hematological parameters should be monitored ...

  • Health Matters : Infant Nutritional Information 7 Nov 2009 18:34 GMT
    ... of vitamin E, which may help prevent anemia by increasing erythrocyte life span, and is ... delivery, if the mother has had little medication and a normal delivery and the newborn ... every 3 to 4 h. The volume consumed in the first feeding is up to ...

  • Clinical study to focus on men, age 7 Nov 2009 11:53 GMT
    ... impaired cognition and cardiovascular disease. The Testosterone Trial at Yale University and 11 other sites ... with the information they need to make treatment decisions. One of our main goals is ... vitality, reduced sexual function, impaired cognition and anemia. The trial is financed largely by the ...

  • Health Matters : What is Idiopathic Thrombocytopenia Purpura ? 7 Nov 2009 18:34 GMT
    ... be misinterpreted as acute leukemia or aplastic anemia. Adults usually develop chronic ITP. It occurs most commonly in ... a child. Acute ITP may require no treatment, especially if the platelet count does not ...

  • Large Study of Anemia Treatment in Chronic Kidney Disease Patients Not on Dialysis Published in the New England Journal of Medicine Failed to Meet Primary Efficacy Endpoints 2 Nov 2009 10:11 GMT
    ... kidney disease (CKD) not on dialysis, moderate anemia and type-2 diabetes. The study, published online ... that there were no significant differences between treatment arms in the incidence of cancer or ... g/dL were given Aranesp as a rescue medication until their hemoglobin level reached 9 g/dL. ...

  • Statin Does Not Enhance Sensitivity to Anemia Treatment 2 Nov 2009 22:32 GMT
    ... this post hoc analysis of a randomized trial found no evidence of increased sensitivity to ... increased sensitivity to erythropoietin therapy from statin treatment in anemic patients on hemodialysis. Note that ... lipids, they apparently don't increase sensitivity to anemia treatment in patients on hemodialysis, a post ...

  • Will New Anemia Drug Top Current Treatments? 4 Nov 2009 22:31 GMT
    ... Will New Anemia Drug Top Current Treatments? Designed for a rare condition, it might have a wider application, experts say WEDNESDAY, ...

  • Schering posts boceprevir trial data, including results for patients not helped by other drugs 2 Nov 2009 12:15 GMT
    ... Schering-Plough Corp. said its experimental hepatitis C drug boceprevir helped eliminate the virus in about ... patients who did not respond to standard treatments. Boceprevir is considered one of the most ... effects in the Schering study were fatigue, anemia, nausea and headache. About half of the ...

  • Schering-Plough reports data on hepatitis C drug 2 Nov 2009 12:10 GMT
    ... - Schering-Plough Corp.said its experimental hepatitis C drug boceprevir helped eliminate the virus in about ... patients who did not respond to standard treatments. Boceprevir is considered one of the most ... effects in the Schering study were fatigue, anemia, nausea and headache. About half of the ...

  • Schering-Plough reports data on hepatitis C drug 2 Nov 2009 12:50 GMT
    ... YORK—Schering-Plough Corp. said its experimental hepatitis C drug boceprevir helped eliminate the virus in about ... patients who did not respond to standard treatments. Boceprevir is considered one of the most ... effects in the Schering study were fatigue, anemia, nausea and headache. About half of the ...

  • Schering-Plough Reports on Hep C Drug 2 Nov 2009 18:53 GMT
    ... Drug Discovery & Development - November 02, 2009 ... patients who did not respond to standard treatments. Boceprevir is considered one of the most ... effects in the Schering study were fatigue, anemia, nausea and headache. About half of the ...

  • Schering posts boceprevir trial data, including results for patients not helped by other drugs 2 Nov 2009 12:36 GMT
    ... drug boceprevir helped eliminate the virus in about ... patients who did not respond to standard treatments. Boceprevir is considered one of the most ... About half of the boceprevir patients developed anemia, a frequent side effect of hepatitis C ...

  • Shire's Gaucher drug gets FDA priority review 5 Nov 2009 19:32 GMT
    ... The U.S. Food and Drug Administration has granted priority review for ’s ... previously announced new drug application for its treatment of Gaucher disease. If approved, the drug ... can result in bone pain and severe anemia. Shire (Nasdaq: SHPGY), whose Human Genetic Therapies ...


1 - 15 / 752      NEXT >>>

Powered by Newsfeed Maker
NOT SATISFIED WITH THIS ANEMIA DRUGS NEWS SECTION? MAKE YOUR OWN WITH THE INBOX ROBOT OR TRY OUR OTHER MEDIA MONITORING SERVICES.
These stories are not published by IPD Group, Inc. and these links will take you to other websites. Some of these websites require their own registration to read their stories.
<<< Please read the disclaimer for more details.>>>
 
 

Take This Poll

According to the White House, 650,000 jobs were created or saved by $150 billion in stimulus funds. Was it money well spent? (Oct. 30, 2009)



 

BUSINESS PROMOTION SERVICES

EIN Advertising · Place banner ads on EIN News industry specific publications.

EIN Presswire · Upload press releases to the EIN network and have them submitted to leading journalists and decision-makers worldwide.

EIN Global Events · Reach industry-specific readers and promote events, conferences or exhibitions.

EIN Business Directory · Present company or service information on highly-visible, industry and geo-specific news pages.

NEWS SERVICES

News Publications · In-depth geopolitical and industry specific news coverage aggregated from 35,000 online outlets. Updated every 15 minutes.

News Alerts · Receive a free selection of the day's top stories hand picked by EIN News editors.

Newsfeed Maker · Integrate customized newsfeeds in any format covering all industry and geopolitical topics, updated every 15 minutes.

EIN Presswire · Upload press releases to the EIN network and have them submitted journalists and decision-makers worldwide.

Inbox Robot · Customized newsletters delivered by e-mail. Search a news index monitoring thousands of trusted media sources.

COMPANY BACKGROUND

About EIN News · Established in 1995, EIN News began by supplying business professionals and individuals with relevant and interesting news products. It has grown to become the largest digital news provider in Europe.

Member List · See the partial member list and join a community of professionals from private industry, institutions, and governments that rely on EIN as a critical source for research, breaking news and media services.